NWA
PROF

Navis Wealth Advisors’s Profound Medical PROF Stock Holding History

Navis Wealth Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,400
Closed -$49K – 170
2020
Q4 		$49K Buy
+2,400
New +$44.2K 0.04% 142

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Navis Wealth Advisors's PROF Position: Q1 2021 in Review

Navis Wealth Advisors sold out of Profound Medical (PROF) in Q1 2021, closing a stake of 2,400 shares — an estimated $49K sold.

Navis Wealth Advisors first reported a position in PROF in Q4 2020 and held it in 1 quarter. The position peaked at $49K in Q4 2020. 54 funds tracked by Wall St. Rank hold PROF as of Q1 2021.

  • Navis Wealth Advisors reported no remaining Profound Medical position as of Q1 2021 after selling out during the quarter.
  • Navis Wealth Advisors sold 2,400 Profound Medical shares in Q1 2021, an estimated $49K.
  • Navis Wealth Advisors first reported a position in Profound Medical in Q4 2020 and held it in 1 quarter.
  • Navis Wealth Advisors's Profound Medical position peaked at $49K in Q4 2020.
  • 54 funds tracked by Wall St. Rank held Profound Medical as of Q1 2021.

Based on Navis Wealth Advisors's 13F filing for Q1 2021, filed 18 May 2021.